BNTX earnings date and last-quarter result: next report 2026-08-03, last quarter miss, P/E -15.68. Updated 2026-07-23.
BioNTech (BNTX) Research Hub
BioNTech (BNTX) trades on NASDAQ, DE in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 86.86 USD (-1.42%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -15.68, market cap 23.24B. This hub links to the full technical, earnings and options research available for BNTX.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, DE |
| Last close | 86.86 USD (-1.42%) |
| 52-week range | 85.85 USD – 120.33 USD |
| Trend regime | Range |
| 14-day RSI | 34.7 (Bearish) |
| Trailing P/E | -15.68 |
| Market cap | 23.24B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-03 |
Available research for BNTX
Covered Call on BNTX: how it works, illustrative setup around the real 86.86 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on BNTX: how it works, illustrative setup around the real 86.86 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on BNTX: how it works, illustrative setup around the real 86.86 USD price, max profit/loss, breakeven and when to use it. Educational.
BNTX technical analysis: range, last 86.86 USD, RSI 34.7, 52w range 85.85 USD–120.33 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is BNTX in?
BioNTech (BNTX) is classified under Healthcare (Biotechnology), listed on NASDAQ, DE.
Is BNTX in an uptrend or downtrend?
As of 2026-10-26, BNTX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is BNTX's trailing P/E ratio?
BNTX's trailing P/E is -15.68, with a market cap of 23.24B. See the earnings research page for full valuation detail.
When does BNTX next report earnings?
BNTX is next scheduled to report earnings on 2026-08-03.